Drugs that contain Sorafenib Tosylate
1. List of Nexavar drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8877933 | BAYER HLTHCARE | Thermodynamically stable form of a tosylate salt |
Dec, 2027
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8618141 | BAYER HLTHCARE | Aryl ureas with angiogenesis inhibiting activity |
Feb, 2023
(3 months ago) | |
| US9737488 | BAYER HLTHCARE | Pharmaceutical composition for the treatment of cancer |
Sep, 2028
(5 years from now) | |
Market Authorisation Date: 20 December, 2005
Treatment: Treatment of advanced renal cell carcinoma; Treatment of locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment; Treatment of unresec...
Dosage: TABLET;ORAL
NEXAVAR family patents
12
United States
7
European Union
5
Korea, Republic of
5
Japan
4
Peru
3
Australia
3
Canada
3
Denmark
3
Spain
3
Cyprus
3
Portugal
3
Hong Kong
3
Slovenia
3
China
2
Israel
2
Croatia
2
New Zealand
2
Honduras
2
Malaysia
2
Singapore
2
Ukraine
2
Poland
2
Morocco
2
Norway
2
Mexico
2
Argentina
2
Cuba
2
South Africa
2
Brazil
2
Guatemala
2
Taiwan
1
Ecuador
1
Dominican Republic
1
Tunisia
1
Uruguay
1
Costa Rica
1
Austria
1
Russia
1
Germany
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic